Position in DHR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,419,647
+$872,659 QoQ
Shares Held
7,453
+169.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#977
of 2,098 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $15,330,453 across 13 Diagnostics & Research names. DHR ranks #6 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
4,967 | $2,614,827 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,373 | $2,192,447 | |
| 3 | GH |
Guardant Health, Inc.
|
14,194 | $2,129,525 | |
| 4 | NTRA |
Natera, Inc.
|
5,952 | $1,615,670 | |
| 5 | ICLR |
Icon PLC
|
8,750 | $1,519,962 | |
| 6 | DHR |
Danaher Corp /De/
This page
|
7,453 | $1,419,647 | |
| 7 | ILMN |
Illumina, Inc.
|
5,605 | $985,527 | |
| 8 | VCYT |
Veracyte, Inc.
|
11,062 | $649,671 |
All Filings in DHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,419,647 | 7,453 | Shares | Sole | 2026-08-04 | |
| 2025-06-30 | $546,988 | 2,769 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $648,620 | 3,164 | Shares | Sole | 2025-05-13 | |
| 2024-09-30 | $397,012 | 1,428 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $334,799 | 1,340 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $628,550 | 2,717 | Shares | Sole | 2024-02-13 | |
| 2023-03-31 | $1,180,303 | 4,683 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $973,009 | 3,838 | Shares | Sole | 2022-08-12 | |
| 2020-12-31 | $246,797 | 1,111 | Shares | Sole | 2021-02-08 | |
| 2020-03-31 | $263,394 | 1,903 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||